Yahoo Web Search

Search results

1. • Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

     Zacks· 4 days ago

     The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has gained 4.4% over this period. Now the key question is: Where could the

2. • Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)

     ETF DAILY NEWS· 18 hours ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on ...

3. • AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages

     ETF DAILY NEWS· 6 days ago

     Three research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month target price ...

4. • 

     AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com

     Investing.com· 3 days ago

     On Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...

5. • 

     3 Magnificent Stocks That Are Passive Income Machines

     Motley Fool via Yahoo Finance· 4 days ago

     Novartis is a dependable growth stock with a high yield David Jagielski (Novartis): One healthcare ...

6. • 

     Are You Looking for a High-Growth Dividend Stock?

     Zacks via Yahoo Finance· 1 day ago

     Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...

7. • 

     Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

     Motley Fool via Yahoo Finance· 7 days ago

     Over time, that's potentially 10% to 11% of total returns, which can quickly build wealth for...

8. • 

     Earnings call: AbbVie projects robust growth and diversified pipeline By Investing.com

     Investing.com· 2 days ago

     With a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...

9. • 

     Bernard Horn's Polaris Global Value Fund 1st-Quarter Letter: Loo

     Guru Focus· 3 hours ago

     Global equity markets enjoyed consecutive months of gains, with the MSCI World Index returning 8.88%...

10. • 

      Is Eli Lilly Stock A Better Pick Over Amgen?

      Forbes· 5 days ago

      Also, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...